Imperial College London

ProfessorJimCrawley

Faculty of MedicineDepartment of Immunology and Inflammation

Professor of Haemostasis
 
 
 
//

Contact

 

+44 (0)20 3313 2297j.crawley Website

 
 
//

Location

 

5S5aCommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Schelpe:2020:10.1182/bloodadvances.2019001375,
author = {Schelpe, A-S and Petri, A and Roose, E and Pareyn, I and Deckmyn, H and De, Meyer SF and Crawley, JTB and Vanhoorelbeke, K},
doi = {10.1182/bloodadvances.2019001375},
journal = {Blood Advances},
pages = {1072--1080},
title = {Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function},
url = {http://dx.doi.org/10.1182/bloodadvances.2019001375},
volume = {4},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Plasma ADAMTS13 circulates in a folded conformation that is stabilized by an interaction between the central Spacer domain and the C-terminal CUB (complement components C1r and C1s, sea urchin protein Uegf, and bone morphogenetic protein-1) domains. Binding of ADAMTS13 to the VWF D4(-CK) domains or to certain activating murine monoclonal antibodies (mAbs) induces a structural change that extends ADAMTS13 into an open conformation that enhances its function. The objective was to characterize the mechanism by which conformational activation enhances ADAMTS13-mediated proteolysis of VWF. The activating effects of a novel anti-Spacer (3E4) and the anti-CUB1 (17G2) mAbs on the kinetics of proteolysis of VWF A2 domain fragments by ADAMTS13 were analyzed. mAb-induced conformational changes in ADAMTS13 were investigated by enzyme-linked immunosorbent assay. Both mAbs enhanced ADAMTS13 catalytic efficiency (kcat/Km) by ∼twofold (3E4: 2.0-fold; 17G2: 1.8-fold). Contrary to previous hypotheses, ADAMTS13 activation was not mediated through exposure of the Spacer or cysteine-rich domain exosites. Kinetic analyses revealed that mAb-induced conformational extension of ADAMTS13 enhances the proteolytic function of the metalloprotease domain (kcat), rather than augmenting substrate binding (Km). A conformational effect on the metalloprotease domain was further corroborated by the finding that incubation of ADAMTS13 with either mAb exposed a cryptic epitope in the metalloprotease domain that is normally concealed when ADAMTS13 is in a closed conformation. We show for the first time that the primary mechanism of mAb-induced conformational activation of ADAMTS13 is not a consequence of functional exosite exposure. Rather, our data are consistent with an allosteric activation mechanism on the metalloprotease domain that augments active site function.
AU - Schelpe,A-S
AU - Petri,A
AU - Roose,E
AU - Pareyn,I
AU - Deckmyn,H
AU - De,Meyer SF
AU - Crawley,JTB
AU - Vanhoorelbeke,K
DO - 10.1182/bloodadvances.2019001375
EP - 1080
PY - 2020///
SN - 2473-9529
SP - 1072
TI - Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function
T2 - Blood Advances
UR - http://dx.doi.org/10.1182/bloodadvances.2019001375
UR - https://ashpublications.org/bloodadvances/article/4/6/1072/452721/Antibodies-that-conformationally-activate-ADAMTS13
UR - http://hdl.handle.net/10044/1/77752
VL - 4
ER -